US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

8.560 +0.060 (+0.71%)
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Earnings Preview For Harvard Bioscience ↗
 
Via Benzinga
News headline image
Preview: Harvard Bioscience's Earnings ↗
 
Via Benzinga
News headline image
Why Harvard Bioscience Stock Rose This Week ↗
The company reported improved revenue in Q1. 
Via The Motley Fool
News headline image
Harvard Bioscience's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 7, 2024 ↗
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
News headline image
A Preview Of Harvard Bioscience's Earnings ↗
 
Via Benzinga
News headline image
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Third Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
Innovative solutions for academic, CRO, pharma and biotech customers 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
From Harvard Bioscience, Inc.; Etisense
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Harvard Bioscience Announces Second Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
Has served in interim role since January 2023 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces First Quarter 2023 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
Designed to meet the pre-clinical testing needs of CROs, pharma and research laboratories 
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗
The Dow Jones closed lower by more than 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
News headline image
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >